Skip to main content
Drug development for newborn brain injury.
Hypoxanthine-early biomarker of outcomes in an ovine model of neonatal hypoxic ischemic encephalopathy.
Systematic review of terminology, definitions, and eligibility criteria in trials of neonatal encephalopathy, hypoxic-ischemic encephalopathy, and perinatal asphyxia.
Updated recommendations for the design of therapeutic trials for neonatal seizures.
Clinical outcomes of influenza in individuals aged ≤20 years before and after COVID-19: a national analysis of mortality and complications.
Metabolic response to extended continuous positive airway pressure in premature infants.
All roads lead to Rome: the fetal heart-brain connection.
Social epidemiology of multidimensional sleep health in early adolescence.
Social epidemiology of gender diversity in early adolescents.
Cumulative caffeine exposure predicts neurodevelopmental outcomes in premature infants.